MicroRNA-216a promotes the metastasis and epithelial–mesenchymal transition of ovarian cancer by suppressing the PTEN/AKT pathway

Haizhi LiuDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of JiNan University, Guangzhou, People’s Republic of China

Ying PanDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of JiNan University, Guangzhou, People’s Republic of China

Xiaoxue HanDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of JiNan University, Guangzhou, People’s Republic of China

Jia LiuDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of JiNan University, Guangzhou, People’s Republic of China

Ruiman LiDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of JiNan University, Guangzhou, People’s Republic of ChinaCorrespondence[email protected]

Pages 2701-2709 | Published online: 23 May 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

HennessyBTColemanRLMarkmanMOvarian cancerLancet200937496981371138219793610
PubMed Web of Science ®Google Scholar
DeSantisCELinCCMariottoABCancer treatment and survivorship statistics, 2014CA Cancer J Clin201464425227124890451
PubMed Web of Science ®Google Scholar
BastRCHennessyBMillsGBThe biology of ovarian cancer: new opportunities for translationNat Rev Cancer20099641542819461667
PubMed Web of Science ®Google Scholar
MezzanzanicaDOvarian cancer: a molecularly insidious diseaseChinese J Cancer20153411
PubMedGoogle Scholar
HolschneiderCHBerekJSOvarian cancer: epidemiology, biology, and prognostic factorsPaper presented at: Seminars in Surgical Oncology2000
Google Scholar
BartelDPMicroRNAs: genomics, biogenesis, mechanism, and functionCell2004116228129714744438
PubMed Web of Science ®Google Scholar
MendellJTMicroRNAs: critical regulators of development, cellular physiology and malignancyCell Cycle2005491179118416096373
PubMed Web of Science ®Google Scholar
ChongGOJeonH-SHanHSDifferential microRNA expression profiles in primary and recurrent epithelial ovarian cancerAnticancer Res20153552611261725964536
PubMed Web of Science ®Google Scholar
LlauradóMMajemBAltadillTMicroRNAs as prognostic markers in ovarian cancerMol Cell Endocrinol20143901738424747602
PubMedGoogle Scholar
LuJGetzGMiskaEAMicroRNA expression profiles classify human cancersNature2005435704383483815944708
PubMed Web of Science ®Google Scholar
ZhangSLuZUnruhAKClinically relevant microRNAs in ovarian cancerMol Cancer Res201513339340125304686
PubMed Web of Science ®Google Scholar
IorioMVVisoneRDi LevaGMicroRNA signatures in human ovarian cancerCancer Res200767188699870717875710
PubMed Web of Science ®Google Scholar
CalinGACroceCMMicroRNA signatures in human cancersNat Rev Cancer200661185786617060945
PubMed Web of Science ®Google Scholar
MezzanzanicaDBagnoliMDe CeccoLValeriBCanevariSRole of microRNAs in ovarian cancer pathogenesis and potential clinical implicationsInt J Biochem Cell Biol20104281262127220035894
PubMedGoogle Scholar
WangR-TXuMXuC-XSongZ-GJinHDecreased expression of miR216a contributes to non–small-cell lung cancer progressionClin Cancer Res201420174705471624958806
PubMedGoogle Scholar
WangSChenXTangMMicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2Oncol Rep20143262824283025220761
PubMedGoogle Scholar
LiLMaHQMicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4BMol Med Rep20151223156316225955794
PubMedGoogle Scholar
GregoryRIShiekhattarRMicroRNA biogenesis and cancerCancer Res20056593509351215867338
PubMed Web of Science ®Google Scholar
SassenSMiskaEACaldasCMicroRNA – implications for cancerVirchows Archiv2008452111018040713
PubMed Web of Science ®Google Scholar
CorneyDCNikitinAYMicroRNA and ovarian cancerHistol Histopathol2008239116118581287
PubMedGoogle Scholar
XiaHOoiLLPHuiKMMicroRNA-216a/217-induced epithelialmesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancerHepatology201358262964123471579
PubMed Web of Science ®Google Scholar
ChalhoubNBakerSJPTEN and the PI3-kinase pathway in cancerAnn Rev Pathol2009412718767981
PubMed Web of Science ®Google Scholar
Di CristofanoAPandolfiPPThe multiple roles of PTEN in tumor suppressionCell2000100438739010693755
PubMed Web of Science ®Google Scholar
CarneroABlanco-AparicioCRennerOLinkWLealJFThe PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implicationsCurr Cancer Drug Targets20088318719818473732
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

MicroRNA-216a promotes the metastasis and epithelial–mesenchymal transition of ovarian cancer by suppressing the PTEN/AKT pathway

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

MicroRNA-216a promotes the metastasis and epithelial–mesenchymal transition of ovarian cancer by suppressing the PTEN/AKT pathway

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date